Form 8-K - Current report:
SEC Accession No. 0001753926-25-001425
Filing Date
2025-09-03
Accepted
2025-09-03 08:31:18
Documents
36
Period of Report
2025-09-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084940_8-k.htm   iXBRL 8-K 27494
2 EXHIBIT 99.1 g084940_ex99-1.htm EX-99.1 35112
3 EXHIBIT 99.2 g084940_ex99-2.htm EX-99.2 6801
4 GRAPHIC img001_v1.jpg GRAPHIC 3770
5 GRAPHIC img002_v1.jpg GRAPHIC 70356
6 GRAPHIC img003_v1.jpg GRAPHIC 187565
7 GRAPHIC img004_v1.jpg GRAPHIC 734524
8 GRAPHIC img005_v1.jpg GRAPHIC 144997
9 GRAPHIC img006_v1.jpg GRAPHIC 79388
10 GRAPHIC img007_v1.jpg GRAPHIC 49039
11 GRAPHIC img008_v1.jpg GRAPHIC 149388
12 GRAPHIC img009_v1.jpg GRAPHIC 124527
13 GRAPHIC img010_v1.jpg GRAPHIC 145218
14 GRAPHIC img011_v1.jpg GRAPHIC 101926
15 GRAPHIC img012_v1.jpg GRAPHIC 49263
16 GRAPHIC img013_v1.jpg GRAPHIC 665552
17 GRAPHIC img014_v1.jpg GRAPHIC 106046
18 GRAPHIC img015_v1.jpg GRAPHIC 124380
19 GRAPHIC img016_v1.jpg GRAPHIC 87234
20 GRAPHIC img017_v1.jpg GRAPHIC 52857
21 GRAPHIC img018_v1.jpg GRAPHIC 111839
22 GRAPHIC img019_v1.jpg GRAPHIC 106895
23 GRAPHIC img020_v1.jpg GRAPHIC 97372
24 GRAPHIC img021_v1.jpg GRAPHIC 149052
25 GRAPHIC img022_v1.jpg GRAPHIC 67158
  Complete submission text file 0001753926-25-001425.txt   4949463

Data Files

Seq Description Document Type Size
26 XBRL SCHEMA FILE pths-20250902.xsd EX-101.SCH 3011
27 XBRL LABEL FILE pths-20250902_lab.xml EX-101.LAB 34239
28 XBRL PRESENTATION FILE pths-20250902_pre.xml EX-101.PRE 22356
38 EXTRACTED XBRL INSTANCE DOCUMENT g084940_8-k_htm.xml XML 3808
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 251287822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)